Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2026-01-29 @ 9:33 AM
Study NCT ID:
NCT05669820
Status:
RECRUITING
Last Update Posted:
2024-02-05
First Post:
2022-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Antisecretory Factor Glioblastoma Phase 2
Sponsor:
Peter Siesjö
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FPAFGB2ver6
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |